The lifetime risk of patients with NF-1 developing MPNSTs has been estimated at 813%, with a yearly risk of developing MPNSTs of 0.16% compared to 0.001% in the general population
A recent retrospective cohort study looked at GLP-1 adherence in patients with obesity and with/without diabetes: Those with T2DM: 46.5% discontinued by year one 64.1% discontinued by year two Those without T2DM: 64.8% discontinued by year one 84.4% discontinued by year two So yes access is a problem
How often should I schedule B12 injections to maintain optimal wellness
Book your appointment with me, Dr
Our IV Treatment Options at Hush LA Medspa At Hush LA Medspa, we offer a curated selection of wellness-focused IV therapies designed to support energy, immunity, hydration, recovery, and long-term health
Contact Us UroFill Clinic Form - GF Initial general contact form for UroFill Clinic inquiries